The therapeutic scenario of systemic treatments for hepatocellular carcinoma (HCC) is rapidly changing. There is much interest in the possibility of combining new therapies with surgery, but clinical data is lacking. We aimed to provide an example of such integration.
Elisabetta Goio, Luca Ielasi, Francesca Benevento, Matteo Renzulli, Francesco Tovoli (2020). Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery. HEPATIC ONCOLOGY, 7(3), 1-6 [10.2217/hep-2020-0014].
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery
Elisabetta GoioPrimo
;Luca IelasiSecondo
;Francesca Benevento;Matteo Renzulli;Francesco Tovoli
Ultimo
2020
Abstract
The therapeutic scenario of systemic treatments for hepatocellular carcinoma (HCC) is rapidly changing. There is much interest in the possibility of combining new therapies with surgery, but clinical data is lacking. We aimed to provide an example of such integration.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
hep-2020-0014.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione
2.39 MB
Formato
Adobe PDF
|
2.39 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
